94 results
Page 3 of 5
8-K
EX-99.1
10br84khg
19 May 22
Pulse Biosciences, Inc. Announces Changes to its Rights Offering
8:28am
8-K
EX-99.1
vy0jo8q7itd72l
11 May 22
Pulse Biosciences Reports First Quarter 2022 Financial Results
4:21pm
8-K
EX-99.7
5xsey fq078
4 May 22
Other Events
8:20am
8-K
EX-99.1
5os4ir46e2xghqw
14 Apr 22
Pulse Biosciences, Inc. Announces Rights Offering
4:23pm
8-K
EX-99.1
qpsnj49jpq38i 6hodw
31 Mar 22
Pulse Biosciences Reports Fourth Quarter & Full Year 2021 Financial Results
4:19pm
8-K
EX-99.1
g9pdo7 vgnpijzku
15 Feb 22
Pulse Biosciences Announces the Appointment of Kevin Danahy as Chief Commercial Officer
9:26am
8-K
EX-99.1
vy5 k7iil7j
8 Feb 22
Pulse Biosciences Provides an Update on Recent FDA 510(k) Submission
8:58am
8-K
EX-99.1
s40nifd1i339
11 Jan 22
Pulse Biosciences Announces Preliminary Fourth Quarter and Full Year 2021 Financial and Operational Results
9:07am
8-K
EX-99.1
oqi8zzug33q5qmk2qg
15 Nov 21
Pulse Biosciences Reports Third Quarter 2021 Financial Results
12:00am
8-K
EX-99.1
lcbh6c
6 Oct 21
Pulse Biosciences Appoints Laureen DeBuono to Its Board of Directors
9:02am
8-K
EX-99.1
8xufy
20 Aug 21
Pulse Biosciences Announces Appointment of Mitchell E. Levinson as Chief Strategy Officer
4:11pm
8-K
EX-99.1
ou2c87jg0duhx9ey1r
9 Aug 21
Pulse Biosciences Reports Second Quarter 2021 Financial Results
4:32pm
8-K
EX-99.1
7vncjmq1kkr8i11qk3
1 Jul 21
Pulse Biosciences Announces $50 Million Private Placement
8:33am
8-K
EX-99.1
rrd1yceapr 5hk
9 Jun 21
Pulse Biosciences Announces Health Canada Approval for CellFX® System
8:22am
8-K
EX-99.1
cpr5gia2u 1oo1
10 May 21
Pulse Biosciences Reports First Quarter 2021 Financial Results
4:23pm